Ewing, NJ, United States of America

Georgia Arvanitis

This inventor holds 3 USPTO granted patents. Top assignee: Warner-Lambert Company. Active years: 2004-2005.


% Patents Active = 33.3

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2004-2005

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Georgia Arvanitis: Innovator in Oral Care Compositions

Introduction

Georgia Arvanitis is a notable inventor based in Ewing, NJ (US). She has made significant contributions to the field of oral care through her innovative research and development. With a total of 3 patents to her name, her work focuses on improving oral health for warm-blooded animals, including humans.

Latest Patents

One of her latest patents involves substituted tropolone compounds and oral care compositions containing these compounds. This invention relates to novel tropolone compounds that are effective in preventing or treating diseases or conditions of the oral cavity. The oral care compositions comprise an effective amount of at least one novel tropolone compound and a pharmaceutically acceptable oral carrier. Furthermore, the invention outlines a method for applying these compositions to the oral cavity to achieve the desired therapeutic effects.

Career Highlights

Georgia Arvanitis is associated with Warner-Lambert Company, where she has been instrumental in advancing oral care technologies. Her work has not only contributed to the company's portfolio but has also had a positive impact on public health.

Collaborations

Throughout her career, Georgia has collaborated with esteemed colleagues such as Pauline H Pan and Marybeth Finnegan. These partnerships have fostered a collaborative environment that enhances innovation and research in oral care.

Conclusion

Georgia Arvanitis stands out as a pioneering inventor in the realm of oral care compositions. Her contributions through her patents and collaborations continue to influence the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…